MR spectroscopy: A powerful tool for investigating brain function and neurological diseases

被引:24
作者
Burlina, AP
Aureli, T
Bracco, F
Conti, F
Battistin, L
机构
[1] Univ Padua, Dept Neurol & Psychiat Sci, I-35128 Padua, Italy
[2] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy
关键词
proton MR spectroscopy; brain tumors; multiple sclerosis; inborn errors of metabolism; N-acetylasparatate; review;
D O I
10.1023/A:1007660632520
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Magnetic resonance spectroscopy (MRS) has attracted much attention in recent years and has become an important tool to study in vivo particular biochemical aspects of brain disorders. Since the proton is the most sensitive stable nucleus for MRS, and since almost all metabolites contain hydrogen atoms, investigation by in vivo H-1 MRS provides chemical information on tissue metabolites, thus enabling a non-invasive assessment of changes in brain metabolism underlying several brain diseases. In this review a brief description of the basic principles of MRS is given. Moreover, we provide some explanations on the techniques and technical problems related to the use of H-1 MRS in vivo including water suppression, localization, editing, quantitation and interpretation of H-1 spectra. Finally, we discuss the more recent advancement in three major areas of neurological diseases: brain tumors, multiple sclerosis, and inborn errors of metabolism.
引用
收藏
页码:1365 / 1372
页数:8
相关论文
共 72 条
[1]   MAPPING OF METABOLITES IN WHOLE ANIMALS BY P-31 NMR USING SURFACE COILS [J].
ACKERMAN, JJH ;
GROVE, TH ;
WONG, GG ;
GADIAN, DG ;
RADDA, GK .
NATURE, 1980, 283 (5743) :167-170
[2]  
ANDREW ER, 1990, CLIN MAGNETIC RESONA
[3]   PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF HUMAN BRAIN INVIVO IN THE EVALUATION OF MULTIPLE-SCLEROSIS - ASSESSMENT OF THE LOAD OF DISEASE [J].
ARNOLD, DL ;
MATTHEWS, PM ;
FRANCIS, G ;
ANTEL, J .
MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (01) :154-159
[4]   USE OF PROTON MAGNETIC-RESONANCE SPECTROSCOPY FOR MONITORING DISEASE PROGRESSION IN MULTIPLE-SCLEROSIS [J].
ARNOLD, DL ;
RIESS, GT ;
MATTHEWS, PM ;
FRANCIS, GS ;
COLLINS, DL ;
WOLFSON, C ;
ANTEL, JP .
ANNALS OF NEUROLOGY, 1994, 36 (01) :76-82
[5]   The entry of [1-C-13]glucose into biochemical pathways reveals a complex compartmentation and metabolite trafficking between glia and neurons: a study by C-13-NMR spectroscopy [J].
Aureli, T ;
DiCocco, ME ;
Calvani, M ;
Conti, F .
BRAIN RESEARCH, 1997, 765 (02) :218-227
[6]   HIGH-RESOLUTION H-1 NUCLEAR MAGNETIC-RESONANCE STUDY OF CEREBRAL HYPOXIA INVIVO [J].
BEHAR, KL ;
DENHOLLANDER, JA ;
STROMSKI, ME ;
OGINO, T ;
SHULMAN, RG ;
PETROFF, OAC ;
PRICHARD, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (16) :4945-4948
[7]   In vitro expression of N-acetyl aspartate by oligodendrocytes:: Implications for proton magnetic resonance spectroscopy signal in vivo [J].
Bhakoo, KK ;
Pearce, D .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) :254-262
[8]   INVIVO VOLUME-SELECTIVE METABOLITE EDITING VIA CORRELATED Z-ORDER [J].
BRERETON, IM ;
ROSE, SE ;
GALLOWAY, GJ ;
MOXON, LN ;
DODDRELL, DM .
MAGNETIC RESONANCE IN MEDICINE, 1990, 16 (03) :460-469
[9]   N-acetylaspartylglutamate in Canavan disease: an adverse effector? [J].
Burlina, AP ;
Ferrari, V ;
Divry, P ;
Gradowska, W ;
Jakobs, C ;
Bennett, MJ ;
Sewell, AC ;
Dionisi-Vici, C ;
Burlina, AB .
EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (05) :406-409
[10]   DETECTION OF INCREASED URINARY N-ACETYLASPARTYLGLUTAMATE IN CANAVAN DISEASE [J].
BURLINA, AP ;
CORAZZA, A ;
FERRARI, V ;
ERHARD, P ;
KUNNECKE, B ;
SEELIG, J ;
BURLINA, AB .
EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (07) :538-539